Search Results - "Reto, Guler"

Refine Results
  1. 1

    The gut microbiome in tuberculosis susceptibility and treatment response: guilty or not guilty? by Eribo, Osagie A., du Plessis, Nelita, Ozturk, Mumin, Guler, Reto, Walzl, Gerhard, Chegou, Novel N.

    “…Although tuberculosis (TB) is a curable disease, it remains the foremost cause of death from a single pathogen. Globally, approximately 1.6 million people died…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Targeting Batf2 for infectious diseases and cancer by Guler, Reto, Roy, Sugata, Suzuki, Harukazu, Brombacher, Frank

    Published in Oncotarget (29-09-2015)
    “…The family members Batf, Batf2 and Batf3 belong to a class of transcription factors containing basic leucine zipper domains that regulate various immunological…”
    Get full text
    Journal Article
  4. 4

    Transcriptionally induced enhancers in the macrophage immune response to Mycobacterium tuberculosis infection by Denisenko, Elena, Guler, Reto, Mhlanga, Musa, Suzuki, Harukazu, Brombacher, Frank, Schmeier, Sebastian

    Published in BMC genomics (22-01-2019)
    “…Tuberculosis is a life-threatening infectious disease caused by Mycobacterium tuberculosis (M.tb). M.tb subverts host immune responses to build a favourable…”
    Get full text
    Journal Article
  5. 5

    Targeting Molecular Inflammatory Pathways in Granuloma as Host-Directed Therapies for Tuberculosis by Guler, Reto, Ozturk, Mumin, Sabeel, Solima, Motaung, Bongani, Parihar, Suraj P, Thienemann, Friedrich, Brombacher, Frank

    Published in Frontiers in immunology (20-10-2021)
    “…Globally, more than 10 million people developed active tuberculosis (TB), with 1.4 million deaths in 2020. In addition, the emergence of drug-resistant strains…”
    Get full text
    Journal Article
  6. 6
  7. 7

    MIREyA: a computational approach to detect miRNA-directed gene activation [version 2; peer review: 1 approved, 2 approved with reservations] by Elizarova, Anna, Ozturk, Mumin, Guler, Reto, Medvedeva, Yulia A

    Published in F1000 research (2021)
    “…Emerging studies demonstrate the ability of microRNAs (miRNAs) to activate genes via different mechanisms. Specifically, miRNAs may trigger an enhancer…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Antisense Therapy for Infectious Diseases by Buthelezi, Lwanda Abonga, Pillay, Shandre, Ntuli, Noxolo Nokukhanya, Gcanga, Lorna, Guler, Reto

    Published in Cells (Basel, Switzerland) (01-08-2023)
    “…Infectious diseases, particularly Tuberculosis (TB) caused by , pose a significant global health challenge, with 1.6 million reported deaths in 2021, making it…”
    Get full text
    Journal Article
  11. 11

    Evaluation of Berberine as an Adjunct to TB Treatment by Ozturk, Mumin, Chia, Julius E, Hazra, Rudranil, Saqib, Mohd, Maine, Rebeng A, Guler, Reto, Suzuki, Harukazu, Mishra, Bibhuti B, Brombacher, Frank, Parihar, Suraj P

    Published in Frontiers in immunology (20-10-2021)
    “…Tuberculosis (TB) is the global health problem with the second highest number of deaths from a communicable disease after COVID-19. Although TB is curable,…”
    Get full text
    Journal Article
  12. 12

    IL-4-Responsive B Cells Are Detrimental During Chronic Tuberculosis Infection in Mice by Parihar, Suraj P., Ozturk, Mumin, Höft, Maxine A., Chia, Julius E., Guler, Reto, Keeton, Roanne, van Rensburg, Ilana C., Loxton, Andre G., Brombacher, Frank

    Published in Frontiers in immunology (15-06-2021)
    “…In tuberculosis, T cell-mediated immunity is extensively studied whilst B cells received limited attention in human and mice. Of interest, Mycobacterium…”
    Get full text
    Journal Article
  13. 13

    Deletion of N-acetylmuramyl-L-alanine amidases alters the host immune response to Mycobacterium tuberculosis infection by Kieswetter, Nathan Scott, Ozturk, Mumin, Jones, Shelby-Sara, Senzani, Sibusiso, Chengalroyen, Melissa Dalcina, Brombacher, Frank, Kana, Bavesh, Guler, Reto

    Published in Virulence (01-12-2021)
    “…Peptidoglycan (PG), a heteropolysaccharide component of the mycobacterial cell wall can be shed during tuberculosis infection with immunomodulatory…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    COVID-19Base v3: Update of the knowledgebase for drugs and biomedical entities linked to COVID-19 by Basit, Syed Abdullah, Qureshi, Rizwan, Musleh, Saleh, Guler, Reto, Rahman, M Sohel, Biswas, Kabir H, Alam, Tanvir

    Published in Frontiers in public health (06-03-2023)
    “…COVID-19 has taken a huge toll on our lives over the last 3 years. Global initiatives put forward by all stakeholders are still in place to combat this…”
    Get full text
    Journal Article
  17. 17

    Lyl1-deficiency promotes inflammatory responses and increases mycobacterial burden in response to Mycobacterium tuberculosis infection in mice by Jones, Shelby-Sara, Ozturk, Mumin, Kieswetter, Nathan Scott, Poswayo, Sibongiseni K L, Hazra, Rudranil, Tamgue, Ousman, Parihar, Suraj P, Suzuki, Harukazu, Brombacher, Frank, Guler, Reto

    Published in Frontiers in immunology (02-09-2022)
    “…Lymphoblastic leukemia 1 (Lyl1) is a well-studied transcription factor known to exhibit oncogenic potential in various forms of leukemia with pivotal roles in…”
    Get full text
    Journal Article
  18. 18

    Simvastatin enhances protection against Listeria monocytogenes infection in mice by counteracting Listeria-induced phagosomal escape by Parihar, Suraj P, Guler, Reto, Lang, Dirk M, Suzuki, Harukazu, Marais, A David, Brombacher, Frank

    Published in PloS one (24-09-2013)
    “…Statins are well-known cholesterol lowering drugs targeting HMG-CoA-reductase, reducing the risk of coronary disorders and hypercholesterolemia. Statins are…”
    Get full text
    Journal Article
  19. 19

    IL-4Rα-dependent alternative activation of macrophages is not decisive for Mycobacterium tuberculosis pathology and bacterial burden in mice by Guler, Reto, Parihar, Suraj P, Savvi, Suzana, Logan, Erin, Schwegmann, Anita, Roy, Sugata, Nieuwenhuizen, Natalie E, Ozturk, Mumin, Schmeier, Sebastian, Suzuki, Harukazu, Brombacher, Frank

    Published in PloS one (19-03-2015)
    “…Classical activation of macrophages (caMph or M1) is crucial for host protection against Mycobacterium tuberculosis (Mtb) infection. Evidence suggests that…”
    Get full text
    Journal Article
  20. 20

    To treat or not to treat tuberculosis –clinical decision making in patients with previous pulmonary tuberculosis using 18F-FDG PET/CT by Günther, Gunar, Abu- Hussain, Nebal, Keller, Peter M., Guler, Reto, Mukasa, Sandra L., Wolmarans, Karen, Thienemann, Friedrich

    Published in Respiratory medicine case reports (2023)
    “…Post-tuberculosis (TB) radiological changes and symptoms can mimic TB. PCR-based diagnostic tests can show positive results, suggesting the presence of…”
    Get full text
    Journal Article